Δεν τις διαβίβαζαν στο e-send από την έναρξη λειτουργίας της επιχείρησης τον Μάιο του 2023
Lavipharm: Focus on the development, production and sale of pharmaceutical products
Lavipharm’s financial figures were presented by the Group’s CFO Vasilis Baloumis, during the annual analyst briefing at the Athens Stock Exchange. The figures reflect dynamic